Tweenvest Stocks

Artrya Limited (ASX: AYA)

Health Care · Health Care Technology · AU

AU$4.53

-6.60% today · +115.7% 1Y

Artrya Limited (ASX: AYA) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $528.10M and employs 43 people.

Over the last twelve months the share price has gained 115.7%, trading between 1.90 and 6.49.

Tweenvest scores Artrya Limited across four factors: quality 27/100. Its strongest factor is quality.

AYA price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$528.10M
Revenue (TTM)
$19.37K
P/E
EPS
-0.17
Dividend yield
Beta (5Y)
0.59
52-week high
AU$6.49
52-week low
AU$1.90
Avg volume (3M)
Shares outstanding
162.96M
Employees
43
Next earnings

About Artrya Limited

Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.

ISIN
AU0000182412
Founded
2018
Listed since
Nov 25, 2021
Exchange
Australian Securities Exchange
Currency
AUD
CompanyMarket capPriceDay
Veeva Systems Inc.NYSE: VEEV$40.36B$246.35-0.85%
Pro Medicus LimitedASX: PME$14.46BAU$193.43+0.96%
M3, Inc.TSE: 2413$7.21B¥1,719.50+0.67%
Sectra AB (publ)OM: SECT B$5.60BSkr275.80-0.79%
Waystar Holding Corp.NasdaqGS: WAY$4.86B$25.33-0.08%
Doximity, Inc.NYSE: DOCS$4.51B$25.17-0.51%
HeartFlow, Inc.NasdaqGS: HTFL$4.37B$50.59+0.78%
Inventurus Knowledge Solutions LimitedNSEI: IKS$3.30BRs1,840.00+6.43%

Browse every Health Care Technology company →

Figures last refreshed Aug 18, 2026.